Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05105503 · ClinicalTrials.gov registry record
Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System
A clinical trial of Dialysis; Complications and Dialysis Access Malfunction, sponsored by Eko Devices.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT05105503: Completed study of Dialysis; Complications and Dialysis Access Malfunction, sponsored by Eko Devices.
NCT05105503 is a study of Dialysis; Complications and Dialysis Access Malfunction that has completed, run by Eko Devices. The registered enrollment target is 22 participants, below the 99-participant average among 4 other Dialysis; Complications trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05105503, a study of Dialysis; Complications and Dialysis Access Malfunction, has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll end-stage renal disease (ESRD) patients on hemodialysis with a maturing arteriovenous fistula (AVF) for hemodialysis access. A study staff member will mark with indelible ink on each participant's skin the three sites on the upper extremity where the Eko CORE digital stethoscope will be used to take sound recordings. 9 recordings will be taken (3 at each site) once per week during weekly dialysis treatments.
Primary Outcome
The maturing AVFs sounds recorded during this study will be used to create a database used for AI/ML model development.
Conditions Studied
Interventions
- DEVICE Eko CORE Digital Stethoscope
Study Locations (1)
North Carolina
- Carolina Dialysis - Carrboro - Carrboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-05-23 |
| Est. Completion | 2024-12-31 |
What the finished NCT05105503 record still lists
NCT05105503 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 99-participant average among 4 other Dialysis; Complications trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Dialysis; Complications appearing as the primary indexed condition, and to 1 intervention - of which Eko CORE Digital Stethoscope is the first listed.
NCT05105503 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05105503 about?
NCT05105503 is a clinical study titled "Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System". This study will enroll end-stage renal disease (ESRD) patients on hemodialysis with a maturing arteriovenous fistula (AVF) for hemodialysis access. A study staff member will mark with indelible ink on each participant's skin the three sites on the upper extremity where the Eko CORE digital stethosco...
What is the current status of trial NCT05105503?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2022-05-23. Estimated completion is 2024-12-31.
What conditions does trial NCT05105503 study?
This clinical trial studies the following conditions: Dialysis; Complications, Dialysis Access Malfunction.
What interventions are being tested in trial NCT05105503?
The interventions under investigation include: Eko CORE Digital Stethoscope (DEVICE).
Who is sponsoring clinical trial NCT05105503?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05105503 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dialysis; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Access Cannulation Trial II
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Structured Program of Exercise for Recipients of Kidney Transplantation
RECRUITING · NA
-
Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI